DRNA

Dicerna Pharmaceuticals Inc

Price:

38.22

USD

Volume:

5,675,031.00

United States | Biotechnology

-119.46 %

Upside

As of 2024-03-04, the Fair Value of Dicerna Pharmaceuticals Inc (DRNA) is -7.44 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 38.22 USD, the upside of Dicerna Pharmaceuticals Inc is -119.46%.

Note: valuation result may not be accurate due to the company's negative EPS.

38.22 USD

Stock Price

-7.44 USD

Fair Price

Peter Lynch's formula is:

DRNA Fair Value

= Earnings Growth Rate x TTM EPS
DRNA Fair Value

= 5.00 x -1.49
DRNA Fair Value

= -7.44
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

- | - | - | - | - | 5Y Avg | |

Net income | - | - | - | - | - | - |

YoY growth | - | - | - | - | - | -% |

Market Cap (mil) | 2,895.55 |

P/E | |

Forward P/E |

EPS | -1.49 |

Avg earnings growth rate | -% |

TTM earnings | -124.45 |